Novo Nordisk A/S (LON:0TDD)
London · Delayed Price · Currency is GBP · Price in USD 59.55
+0.62 (1.05%)
At close: Oct 3, 2025
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 196.44 billion as of October 3, 2025. Its market cap has decreased by -56.66% in one year.
Market Cap
196.44B
Enterprise Value
205.82B
Revenue
35.84B
Ranking
n/a
PE Ratio
15.39
Stock Price
59.55
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 4.46B to 196.44B, an increase of 4,304.15%. That is a compound annual growth rate of 14.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 196.44B | -36.28% |
| Dec 30, 2024 | 308.32B | -14.91% |
| Dec 29, 2023 | 362.35B | 43.42% |
| Dec 30, 2022 | 252.66B | 33.68% |
| Dec 30, 2021 | 189.00B | 57.73% |
| Dec 30, 2020 | 119.83B | 15.27% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.16B |
| HSBC Holdings | 182.91B |
| Shell | 156.99B |
| Unilever | 109.34B |
| Rolls-Royce Holdings | 98.05B |
| Rio Tinto Group | 84.56B |
| British American Tobacco p.l.c. | 83.19B |
| GSK plc | 65.55B |